Journal Article Research Support, Non-U.S. Gov't Review Epublish 117 citations
PubMed: 34868060 DOI: 10.3389/fimmu.2021.782569
Understanding the Connection Between Common Stroke Comorbidities, Their Associated Inflammation, and the Course of the Cerebral Ischemia/Reperfusion Cascade.
Front Immunol 12:782569
Authors: Ćukasz Przykaza
Affiliations
- Laboratory of Experimental and Clinical Neurosurgery, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.
Abstract
Despite the enormous progress in the understanding of the course of the ischemic stroke over the last few decades, a therapy that effectively protects neurovascular units (NVUs) and significantly improves neurological functions in stroke patients has still not been achieved. The reasons for this state are unclear, but it is obvious that the cerebral ischemia and reperfusion cascade is a highly complex phenomenon, which includes the intense neuroinflammatory processes, and comorbid stroke risk factors strongly worsen stroke outcomes and likely make a substantial contribution to the pathophysiology of the ischemia/reperfusion, enhancing difficulties in searching of successful treatment. Common concomitant stroke risk factors (arterial hypertension, diabetes mellitus and hyperlipidemia) strongly drive inflammatory processes during cerebral ischemia/reperfusion; because these factors are often present for a long time before a stroke, causing low-grade background inflammation in the brain, and already initially disrupting the proper functions of NVUs. Broad consideration of this situation in basic research may prove to be crucial for the success of future clinical trials of neuroprotection, vasculoprotection and immunomodulation in stroke. This review focuses on the mechanism by which coexisting common risk factors for stroke intertwine in cerebral ischemic/reperfusion cascade and the dysfunction and disintegration of NVUs through inflammatory processes, principally activation of pattern recognition receptors, alterations in the expression of adhesion molecules and the subsequent pathophysiological consequences.
MeSH
Stroke, Ischemia, Immune System Diseases, Comorbidity, Risk Factors, Therapeutics, Reperfusion, Diabetes Mellitus
Cited by
- Neuroprotective mechanism of salvianolic acid B against cerebral ischemia-reperfusion injury in mice through downregulation of TLR4, p-p38MAPK, p-JNK, NF-ÎșB, and IL-1ÎČ. Immun Inflamm Dis, 2023
- Comorbidity and outcomes among hospitalized patients with stroke: a nationwide inpatient analysis. Front Neurol, 2023
- Neuroprotective effects of nobiletin on cerebral ischemia/reperfusion injury rats by inhibiting Rho/ROCK signaling pathway. Ann Transl Med, 2023
- Quercetin Protects Against Global Cerebral ischemiaâreperfusion Injury by Inhibiting Microglial Activation and Polarization. J Inflamm Res, 2024
- SRGN amplifies microglia-mediated neuroinflammation and exacerbates ischemic brain injury. J Neuroinflammation, 2024
- Dexmedetomidine pretreatment alleviates cerebral ischemia/reperfusion injury by inhibiting neuroinflammation through the JAK2/STAT3 pathway. Braz J Med Biol Res, 2022
- E3 Ubiquitin Ligase FBXO3 Drives Neuroinflammation to Aggravate Cerebral Ischemia/Reperfusion Injury. Int J Mol Sci, 2022
- Potential mechanisms of acupuncture in enhancing cerebral perfusion of ischemic stroke. Front Neurol, 2022
- Diabetic Retinopathy May Covariate With Stroke in Diabetes Mellitus. Cureus, 2022
- The relationship between CALLY index and stroke in hypertensive patients: insights from NHANES. Front Nutr, 2025
- Identification immune-related hub genes in diagnosing atherosclerosis with ischemic stroke through comprehensive bioinformatics analysis and machine learning. Front Neurol, 2025
- NAT10 inhibition alleviates astrocyte autophagy by impeding ac4C acetylation of Timp1 mRNA in ischemic stroke. Acta Pharm Sin B, 2025
- Regulation of the p53âmediated ferroptosis signaling pathway in cerebral ischemia stroke (Review). Exp Ther Med, 2023
- Therapeutic Potential and Mechanisms of Novel Simple O-Substituted Isoflavones against Cerebral Ischemia Reperfusion. Int J Mol Sci, 2022
- The effect of the interaction of sleep onset latency and age on ischemic stroke severity via inflammatory chemokines. Front Neurol, 2024
- Metabolomic and transcriptomic analyses revealed potential mechanisms of Anchusa italica Retz. in alleviating cerebral ischemia-reperfusion injury via Wnt/ÎČ-catenin pathway modulation. Nat Prod Bioprospect, 2025
- Comprehensive analysis of bioinformatics identification TST, SQOR and NRDC is mitochondria-related biomarkers of ischemic cerebral apoplexy. Sci Rep, 2025
- Heart Rate Variability and Autonomic Dysfunction After Stroke: Prognostic Markers for Recovery. Biomedicines, 2025
- Anti-Inflammatory Effects of Natural Products on Cerebral Ischemia. Front Pharmacol, 2022
- Sevoflurane postconditioning ameliorates cerebral ischemia-reperfusion injury in rats via TLR4/MyD88/TRAF6 signaling pathway. Aging (Albany NY), 2023